These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 820435)

  • 41. [Prediction of fetal damage in anti-RH isoimmunization. 2 statistical approaches].
    Feinerman D; Rabarison Y; Rumeau-Rouquette C; Roux F; Boreau T
    J Gynecol Obstet Biol Reprod (Paris); 1973; 2(8):1029-40. PubMed ID: 4220040
    [No Abstract]   [Full Text] [Related]  

  • 42. Genetics in medicine: a review. Immunogenetics. Genetics of immunological deficiency states.
    Clarke CA; Evans DA; Harris R; McConnell RB; Woodrow JC
    Q J Med; 1968 Apr; 37(146):220-41. PubMed ID: 4968507
    [No Abstract]   [Full Text] [Related]  

  • 43. [Status of the prevention of the hemolytic disease of the newborn with gamma globulin in Switzerland].
    de Muralt G; Stampfli K
    Gynaecologia; 1969; 167(5):285-8. PubMed ID: 4184765
    [No Abstract]   [Full Text] [Related]  

  • 44. Rhesus anti-E, anti-c antibodies as a cause of hemolytic disease of the newborn.
    Nair PM; Sabarinathan K; Jayaprakash PA; Vijayalekshmi
    Indian Pediatr; 1983 Sep; 20(9):681-4. PubMed ID: 6427106
    [No Abstract]   [Full Text] [Related]  

  • 45. [Problems of Rhesus prophylaxis].
    Baumgarten K
    Med Lab (Stuttg); 1982 Oct; 35(4):115-21. PubMed ID: 6185833
    [No Abstract]   [Full Text] [Related]  

  • 46. [Attempt at Rhesus-prevention at the end of pregnancy].
    Baumgarten K; Reinold E; Koller A
    Wien Med Wochenschr; 1972 Sep; 122(39):551-2. PubMed ID: 4631515
    [No Abstract]   [Full Text] [Related]  

  • 47. [Obstetric care of pregnant Rh-sensitized women and fetal data in a 20-year clinical experience].
    Lampé L; Smid I; Gulyás P; Szabó Z; Aszódi L
    Orv Hetil; 1971 Mar; 112(10):545-51. PubMed ID: 4996201
    [No Abstract]   [Full Text] [Related]  

  • 48. [Report of the Rhesus-Service of the National Action for Child Welfare 1953-1963].
    Bruynoghe G
    Bull Soc R Belge Gynecol Obstet; 1967; 37(1):9-16. PubMed ID: 4973166
    [No Abstract]   [Full Text] [Related]  

  • 49. [Peculiarities of hormonal colpocytology in women with Rhesus-incompatible pregnancy].
    Timoshenko LV; Novits'ka SM
    Pediatr Akus Ginekol; 1968; 5():35-9. PubMed ID: 4988291
    [No Abstract]   [Full Text] [Related]  

  • 50. Experience with the intrauterine transfusion in severe rhesus erythroblastosis.
    Hofmann D; Holländer HJ; Mast H; Quakernack K; Schellong G
    Geburtshilfe Frauenheilkd; 1971 Sep; 31(9):797-814. PubMed ID: 4999762
    [No Abstract]   [Full Text] [Related]  

  • 51. [The prevention of rhesus immunization with anti-rhesus (D) immunoglobulin. Report of a clinical study carried out in Dutch hospitals].
    Dudok De Wit C; Borst-Eilers E; van der Weerdt CM; Kloosterman GJ
    Ned Tijdschr Geneeskd; 1968 Dec; 112(52):2345-51. PubMed ID: 4974070
    [No Abstract]   [Full Text] [Related]  

  • 52. [Titers and hemolytic late effects of rhesus antibodies in exchange transfusion in newborn infants with hemolytic anemia due to the rhesus factor].
    Ruckstuhl J
    Helv Paediatr Acta; 1970 Jul; 25(3):258-72. PubMed ID: 4996413
    [No Abstract]   [Full Text] [Related]  

  • 53. [The prevention of rhesus hemolytic disease with anti-D gamma globulin].
    Battin J
    Cah Med; 1970 Nov; 11(13):1099-104. PubMed ID: 4100654
    [No Abstract]   [Full Text] [Related]  

  • 54. [Observations concerning the prevention of rhesus immunization in the Netherlands].
    de Bruijne JI; van der Weerdt CM; Stallman HF; Hartgerink MJ; borst-Eilers E; Dudok de Wit C
    Ned Tijdschr Geneeskd; 1968 Dec; 112(52):2367-70. PubMed ID: 4974071
    [No Abstract]   [Full Text] [Related]  

  • 55. [Determination of the ABO Rhesus blood group of the fetus in utero by examination of the epithelial cells of the amniotic fluid by immunofluorescence].
    Seigneurin R; Reboud P; Magnis R; Goullier A
    Ann Biol Clin (Paris); 1967; 25(7):913-7. PubMed ID: 4965532
    [No Abstract]   [Full Text] [Related]  

  • 56. [Materno-fetal incompatibility in the ABO system as a factor of protection against hemolytic disease caused by Rh incompatibility].
    Mollica F
    Minerva Pediatr; 1967 Mar; 19(13):610-1. PubMed ID: 4963996
    [No Abstract]   [Full Text] [Related]  

  • 57. [Importance and frequency of the Rh factor D u ].
    Koller A
    Wien Klin Wochenschr; 1972 Oct; 84(42):665-8. PubMed ID: 4628430
    [No Abstract]   [Full Text] [Related]  

  • 58. [Problems in anti-rhesus (D) immunoprophylaxis].
    Bennebroek Gravenhorst J; Overbeeke MA; van Dijk BA
    Ned Tijdschr Geneeskd; 1984 May; 128(21):1005-9. PubMed ID: 6429554
    [No Abstract]   [Full Text] [Related]  

  • 59. [Serology and prophylaxis of Rhesus-caused hemolytic disease of the newborn].
    Maresch W
    Wien Med Wochenschr; 1966 Nov; 116(46):972-4. PubMed ID: 4966249
    [No Abstract]   [Full Text] [Related]  

  • 60. The rhesus factor (part 2).
    DUNDON S; O'DRISCOLL K; GEOGHEGAN F
    J Ir Med Assoc; 1952 Mar; 30(177):65-9. PubMed ID: 14927994
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.